- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Biopharmaceutical CMO & CRO market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Biopharmaceutical CMO & CRO market size is estimated to be worth US$ 20680 million in 2021 and is forecast to a readjusted size of USD 27600 million by 2028 with a CAGR of 4.2% during review period. Contract Manufacturing accounting for % of the Biopharmaceutical CMO & CRO global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Biologics segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Biopharmaceutical CMO & CRO include Lonza, Boehringer Ingelheim GmbH, Rentschler Biotechnologie GmbH, Inno Biologics Sdn Bhd, and JRS Pharma (Celonic GmbH), etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Biopharmaceutical CMO & CRO market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Biologics
Biosimilars
Market segment by Application, can be divided into
Contract Manufacturing
Contract Research
Market segment by players, this report covers
Lonza
Boehringer Ingelheim GmbH
Rentschler Biotechnologie GmbH
Inno Biologics Sdn Bhd
JRS Pharma (Celonic GmbH)
BIOMEVA GmbH
ProBioGen
FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
TOYOBO CO., LTD
Samsung BioLogics
Patheon
CMC Biologics
Binex Co., Ltd.
AbbVie Inc.
WuXi Biologics.
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Biopharmaceutical CMO & CRO product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Biopharmaceutical CMO & CRO, with revenue, gross margin and global market share of Biopharmaceutical CMO & CRO from 2019 to 2022.
Chapter 3, the Biopharmaceutical CMO & CRO competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Biopharmaceutical CMO & CRO market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Biopharmaceutical CMO & CRO research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Biopharmaceutical CMO & CRO
1.2 Classification of Biopharmaceutical CMO & CRO by Type
1.2.1 Overview: Global Biopharmaceutical CMO & CRO Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Biopharmaceutical CMO & CRO Revenue Market Share by Type in 2021
1.2.3 Biologics
1.2.4 Biosimilars
1.3 Global Biopharmaceutical CMO & CRO Market by Application
1.3.1 Overview: Global Biopharmaceutical CMO & CRO Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Contract Manufacturing
1.3.3 Contract Research
1.4 Global Biopharmaceutical CMO & CRO Market Size & Forecast
1.5 Global Biopharmaceutical CMO & CRO Market Size and Forecast by Region
1.5.1 Global Biopharmaceutical CMO & CRO Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Biopharmaceutical CMO & CRO Market Size by Region, (2017-2022)
1.5.3 North America Biopharmaceutical CMO & CRO Market Size and Prospect (2017-2028)
1.5.4 Europe Biopharmaceutical CMO & CRO Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Biopharmaceutical CMO & CRO Market Size and Prospect (2017-2028)
1.5.6 South America Biopharmaceutical CMO & CRO Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Biopharmaceutical CMO & CRO Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Biopharmaceutical CMO & CRO Market Drivers
1.6.2 Biopharmaceutical CMO & CRO Market Restraints
1.6.3 Biopharmaceutical CMO & CRO Trends Analysis
2 Company Profiles
2.1 Lonza
2.1.1 Lonza Details
2.1.2 Lonza Major Business
2.1.3 Lonza Biopharmaceutical CMO & CRO Product and Solutions
2.1.4 Lonza Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Lonza Recent Developments and Future Plans
2.2 Boehringer Ingelheim GmbH
2.2.1 Boehringer Ingelheim GmbH Details
2.2.2 Boehringer Ingelheim GmbH Major Business
2.2.3 Boehringer Ingelheim GmbH Biopharmaceutical CMO & CRO Product and Solutions
2.2.4 Boehringer Ingelheim GmbH Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Boehringer Ingelheim GmbH Recent Developments and Future Plans
2.3 Rentschler Biotechnologie GmbH
2.3.1 Rentschler Biotechnologie GmbH Details
2.3.2 Rentschler Biotechnologie GmbH Major Business
2.3.3 Rentschler Biotechnologie GmbH Biopharmaceutical CMO & CRO Product and Solutions
2.3.4 Rentschler Biotechnologie GmbH Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Rentschler Biotechnologie GmbH Recent Developments and Future Plans
2.4 Inno Biologics Sdn Bhd
2.4.1 Inno Biologics Sdn Bhd Details
2.4.2 Inno Biologics Sdn Bhd Major Business
2.4.3 Inno Biologics Sdn Bhd Biopharmaceutical CMO & CRO Product and Solutions
2.4.4 Inno Biologics Sdn Bhd Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Inno Biologics Sdn Bhd Recent Developments and Future Plans
2.5 JRS Pharma (Celonic GmbH)
2.5.1 JRS Pharma (Celonic GmbH) Details
2.5.2 JRS Pharma (Celonic GmbH) Major Business
2.5.3 JRS Pharma (Celonic GmbH) Biopharmaceutical CMO & CRO Product and Solutions
2.5.4 JRS Pharma (Celonic GmbH) Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 JRS Pharma (Celonic GmbH) Recent Developments and Future Plans
2.6 BIOMEVA GmbH
2.6.1 BIOMEVA GmbH Details
2.6.2 BIOMEVA GmbH Major Business
2.6.3 BIOMEVA GmbH Biopharmaceutical CMO & CRO Product and Solutions
2.6.4 BIOMEVA GmbH Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 BIOMEVA GmbH Recent Developments and Future Plans
2.7 ProBioGen
2.7.1 ProBioGen Details
2.7.2 ProBioGen Major Business
2.7.3 ProBioGen Biopharmaceutical CMO & CRO Product and Solutions
2.7.4 ProBioGen Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 ProBioGen Recent Developments and Future Plans
2.8 FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
2.8.1 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Details
2.8.2 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Major Business
2.8.3 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Biopharmaceutical CMO & CRO Product and Solutions
2.8.4 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Recent Developments and Future Plans
2.9 TOYOBO CO., LTD
2.9.1 TOYOBO CO., LTD Details
2.9.2 TOYOBO CO., LTD Major Business
2.9.3 TOYOBO CO., LTD Biopharmaceutical CMO & CRO Product and Solutions
2.9.4 TOYOBO CO., LTD Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 TOYOBO CO., LTD Recent Developments and Future Plans
2.10 Samsung BioLogics
2.10.1 Samsung BioLogics Details
2.10.2 Samsung BioLogics Major Business
2.10.3 Samsung BioLogics Biopharmaceutical CMO & CRO Product and Solutions
2.10.4 Samsung BioLogics Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Samsung BioLogics Recent Developments and Future Plans
2.11 Patheon
2.11.1 Patheon Details
2.11.2 Patheon Major Business
2.11.3 Patheon Biopharmaceutical CMO & CRO Product and Solutions
2.11.4 Patheon Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Patheon Recent Developments and Future Plans
2.12 CMC Biologics
2.12.1 CMC Biologics Details
2.12.2 CMC Biologics Major Business
2.12.3 CMC Biologics Biopharmaceutical CMO & CRO Product and Solutions
2.12.4 CMC Biologics Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 CMC Biologics Recent Developments and Future Plans
2.13 Binex Co., Ltd.
2.13.1 Binex Co., Ltd. Details
2.13.2 Binex Co., Ltd. Major Business
2.13.3 Binex Co., Ltd. Biopharmaceutical CMO & CRO Product and Solutions
2.13.4 Binex Co., Ltd. Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Binex Co., Ltd. Recent Developments and Future Plans
2.14 AbbVie Inc.
2.14.1 AbbVie Inc. Details
2.14.2 AbbVie Inc. Major Business
2.14.3 AbbVie Inc. Biopharmaceutical CMO & CRO Product and Solutions
2.14.4 AbbVie Inc. Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 AbbVie Inc. Recent Developments and Future Plans
2.15 WuXi Biologics.
2.15.1 WuXi Biologics. Details
2.15.2 WuXi Biologics. Major Business
2.15.3 WuXi Biologics. Biopharmaceutical CMO & CRO Product and Solutions
2.15.4 WuXi Biologics. Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15.5 WuXi Biologics. Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Biopharmaceutical CMO & CRO Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Biopharmaceutical CMO & CRO Players Market Share in 2021
3.2.2 Top 10 Biopharmaceutical CMO & CRO Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Biopharmaceutical CMO & CRO Players Head Office, Products and Services Provided
3.4 Biopharmaceutical CMO & CRO Mergers & Acquisitions
3.5 Biopharmaceutical CMO & CRO New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Biopharmaceutical CMO & CRO Revenue and Market Share by Type (2017-2022)
4.2 Global Biopharmaceutical CMO & CRO Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Biopharmaceutical CMO & CRO Revenue Market Share by Application (2017-2022)
5.2 Global Biopharmaceutical CMO & CRO Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Biopharmaceutical CMO & CRO Revenue by Type (2017-2028)
6.2 North America Biopharmaceutical CMO & CRO Revenue by Application (2017-2028)
6.3 North America Biopharmaceutical CMO & CRO Market Size by Country
6.3.1 North America Biopharmaceutical CMO & CRO Revenue by Country (2017-2028)
6.3.2 United States Biopharmaceutical CMO & CRO Market Size and Forecast (2017-2028)
6.3.3 Canada Biopharmaceutical CMO & CRO Market Size and Forecast (2017-2028)
6.3.4 Mexico Biopharmaceutical CMO & CRO Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Biopharmaceutical CMO & CRO Revenue by Type (2017-2028)
7.2 Europe Biopharmaceutical CMO & CRO Revenue by Application (2017-2028)
7.3 Europe Biopharmaceutical CMO & CRO Market Size by Country
7.3.1 Europe Biopharmaceutical CMO & CRO Revenue by Country (2017-2028)
7.3.2 Germany Biopharmaceutical CMO & CRO Market Size and Forecast (2017-2028)
7.3.3 France Biopharmaceutical CMO & CRO Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Biopharmaceutical CMO & CRO Market Size and Forecast (2017-2028)
7.3.5 Russia Biopharmaceutical CMO & CRO Market Size and Forecast (2017-2028)
7.3.6 Italy Biopharmaceutical CMO & CRO Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Biopharmaceutical CMO & CRO Revenue by Type (2017-2028)
8.2 Asia-Pacific Biopharmaceutical CMO & CRO Revenue by Application (2017-2028)
8.3 Asia-Pacific Biopharmaceutical CMO & CRO Market Size by Region
8.3.1 Asia-Pacific Biopharmaceutical CMO & CRO Revenue by Region (2017-2028)
8.3.2 China Biopharmaceutical CMO & CRO Market Size and Forecast (2017-2028)
8.3.3 Japan Biopharmaceutical CMO & CRO Market Size and Forecast (2017-2028)
8.3.4 South Korea Biopharmaceutical CMO & CRO Market Size and Forecast (2017-2028)
8.3.5 India Biopharmaceutical CMO & CRO Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Biopharmaceutical CMO & CRO Market Size and Forecast (2017-2028)
8.3.7 Australia Biopharmaceutical CMO & CRO Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Biopharmaceutical CMO & CRO Revenue by Type (2017-2028)
9.2 South America Biopharmaceutical CMO & CRO Revenue by Application (2017-2028)
9.3 South America Biopharmaceutical CMO & CRO Market Size by Country
9.3.1 South America Biopharmaceutical CMO & CRO Revenue by Country (2017-2028)
9.3.2 Brazil Biopharmaceutical CMO & CRO Market Size and Forecast (2017-2028)
9.3.3 Argentina Biopharmaceutical CMO & CRO Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Biopharmaceutical CMO & CRO Revenue by Type (2017-2028)
10.2 Middle East & Africa Biopharmaceutical CMO & CRO Revenue by Application (2017-2028)
10.3 Middle East & Africa Biopharmaceutical CMO & CRO Market Size by Country
10.3.1 Middle East & Africa Biopharmaceutical CMO & CRO Revenue by Country (2017-2028)
10.3.2 Turkey Biopharmaceutical CMO & CRO Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Biopharmaceutical CMO & CRO Market Size and Forecast (2017-2028)
10.3.4 UAE Biopharmaceutical CMO & CRO Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Biopharmaceutical CMO & CRO Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Biopharmaceutical CMO & CRO Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Biopharmaceutical CMO & CRO Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Biopharmaceutical CMO & CRO Revenue (USD Million) by Region (2017-2022)
Table 5. Global Biopharmaceutical CMO & CRO Revenue Market Share by Region (2023-2028)
Table 6. Lonza Corporate Information, Head Office, and Major Competitors
Table 7. Lonza Major Business
Table 8. Lonza Biopharmaceutical CMO & CRO Product and Solutions
Table 9. Lonza Biopharmaceutical CMO & CRO Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Boehringer Ingelheim GmbH Corporate Information, Head Office, and Major Competitors
Table 11. Boehringer Ingelheim GmbH Major Business
Table 12. Boehringer Ingelheim GmbH Biopharmaceutical CMO & CRO Product and Solutions
Table 13. Boehringer Ingelheim GmbH Biopharmaceutical CMO & CRO Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Rentschler Biotechnologie GmbH Corporate Information, Head Office, and Major Competitors
Table 15. Rentschler Biotechnologie GmbH Major Business
Table 16. Rentschler Biotechnologie GmbH Biopharmaceutical CMO & CRO Product and Solutions
Table 17. Rentschler Biotechnologie GmbH Biopharmaceutical CMO & CRO Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Inno Biologics Sdn Bhd Corporate Information, Head Office, and Major Competitors
Table 19. Inno Biologics Sdn Bhd Major Business
Table 20. Inno Biologics Sdn Bhd Biopharmaceutical CMO & CRO Product and Solutions
Table 21. Inno Biologics Sdn Bhd Biopharmaceutical CMO & CRO Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. JRS Pharma (Celonic GmbH) Corporate Information, Head Office, and Major Competitors
Table 23. JRS Pharma (Celonic GmbH) Major Business
Table 24. JRS Pharma (Celonic GmbH) Biopharmaceutical CMO & CRO Product and Solutions
Table 25. JRS Pharma (Celonic GmbH) Biopharmaceutical CMO & CRO Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. BIOMEVA GmbH Corporate Information, Head Office, and Major Competitors
Table 27. BIOMEVA GmbH Major Business
Table 28. BIOMEVA GmbH Biopharmaceutical CMO & CRO Product and Solutions
Table 29. BIOMEVA GmbH Biopharmaceutical CMO & CRO Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. ProBioGen Corporate Information, Head Office, and Major Competitors
Table 31. ProBioGen Major Business
Table 32. ProBioGen Biopharmaceutical CMO & CRO Product and Solutions
Table 33. ProBioGen Biopharmaceutical CMO & CRO Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Corporate Information, Head Office, and Major Competitors
Table 35. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Major Business
Table 36. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Biopharmaceutical CMO & CRO Product and Solutions
Table 37. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Biopharmaceutical CMO & CRO Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. TOYOBO CO., LTD Corporate Information, Head Office, and Major Competitors
Table 39. TOYOBO CO., LTD Major Business
Table 40. TOYOBO CO., LTD Biopharmaceutical CMO & CRO Product and Solutions
Table 41. TOYOBO CO., LTD Biopharmaceutical CMO & CRO Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Samsung BioLogics Corporate Information, Head Office, and Major Competitors
Table 43. Samsung BioLogics Major Business
Table 44. Samsung BioLogics Biopharmaceutical CMO & CRO Product and Solutions
Table 45. Samsung BioLogics Biopharmaceutical CMO & CRO Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Patheon Corporate Information, Head Office, and Major Competitors
Table 47. Patheon Major Business
Table 48. Patheon Biopharmaceutical CMO & CRO Product and Solutions
Table 49. Patheon Biopharmaceutical CMO & CRO Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. CMC Biologics Corporate Information, Head Office, and Major Competitors
Table 51. CMC Biologics Major Business
Table 52. CMC Biologics Biopharmaceutical CMO & CRO Product and Solutions
Table 53. CMC Biologics Biopharmaceutical CMO & CRO Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Binex Co., Ltd. Corporate Information, Head Office, and Major Competitors
Table 55. Binex Co., Ltd. Major Business
Table 56. Binex Co., Ltd. Biopharmaceutical CMO & CRO Product and Solutions
Table 57. Binex Co., Ltd. Biopharmaceutical CMO & CRO Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. AbbVie Inc. Corporate Information, Head Office, and Major Competitors
Table 59. AbbVie Inc. Major Business
Table 60. AbbVie Inc. Biopharmaceutical CMO & CRO Product and Solutions
Table 61. AbbVie Inc. Biopharmaceutical CMO & CRO Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. WuXi Biologics. Corporate Information, Head Office, and Major Competitors
Table 63. WuXi Biologics. Major Business
Table 64. WuXi Biologics. Biopharmaceutical CMO & CRO Product and Solutions
Table 65. WuXi Biologics. Biopharmaceutical CMO & CRO Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 66. Global Biopharmaceutical CMO & CRO Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 67. Global Biopharmaceutical CMO & CRO Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 68. Breakdown of Biopharmaceutical CMO & CRO by Company Type (Tier 1, Tier 2 and Tier 3)
Table 69. Biopharmaceutical CMO & CRO Players Head Office, Products and Services Provided
Table 70. Biopharmaceutical CMO & CRO Mergers & Acquisitions in the Past Five Years
Table 71. Biopharmaceutical CMO & CRO New Entrants and Expansion Plans
Table 72. Global Biopharmaceutical CMO & CRO Revenue (USD Million) by Type (2017-2022)
Table 73. Global Biopharmaceutical CMO & CRO Revenue Share by Type (2017-2022)
Table 74. Global Biopharmaceutical CMO & CRO Revenue Forecast by Type (2023-2028)
Table 75. Global Biopharmaceutical CMO & CRO Revenue by Application (2017-2022)
Table 76. Global Biopharmaceutical CMO & CRO Revenue Forecast by Application (2023-2028)
Table 77. North America Biopharmaceutical CMO & CRO Revenue by Type (2017-2022) & (USD Million)
Table 78. North America Biopharmaceutical CMO & CRO Revenue by Type (2023-2028) & (USD Million)
Table 79. North America Biopharmaceutical CMO & CRO Revenue by Application (2017-2022) & (USD Million)
Table 80. North America Biopharmaceutical CMO & CRO Revenue by Application (2023-2028) & (USD Million)
Table 81. North America Biopharmaceutical CMO & CRO Revenue by Country (2017-2022) & (USD Million)
Table 82. North America Biopharmaceutical CMO & CRO Revenue by Country (2023-2028) & (USD Million)
Table 83. Europe Biopharmaceutical CMO & CRO Revenue by Type (2017-2022) & (USD Million)
Table 84. Europe Biopharmaceutical CMO & CRO Revenue by Type (2023-2028) & (USD Million)
Table 85. Europe Biopharmaceutical CMO & CRO Revenue by Application (2017-2022) & (USD Million)
Table 86. Europe Biopharmaceutical CMO & CRO Revenue by Application (2023-2028) & (USD Million)
Table 87. Europe Biopharmaceutical CMO & CRO Revenue by Country (2017-2022) & (USD Million)
Table 88. Europe Biopharmaceutical CMO & CRO Revenue by Country (2023-2028) & (USD Million)
Table 89. Asia-Pacific Biopharmaceutical CMO & CRO Revenue by Type (2017-2022) & (USD Million)
Table 90. Asia-Pacific Biopharmaceutical CMO & CRO Revenue by Type (2023-2028) & (USD Million)
Table 91. Asia-Pacific Biopharmaceutical CMO & CRO Revenue by Application (2017-2022) & (USD Million)
Table 92. Asia-Pacific Biopharmaceutical CMO & CRO Revenue by Application (2023-2028) & (USD Million)
Table 93. Asia-Pacific Biopharmaceutical CMO & CRO Revenue by Region (2017-2022) & (USD Million)
Table 94. Asia-Pacific Biopharmaceutical CMO & CRO Revenue by Region (2023-2028) & (USD Million)
Table 95. South America Biopharmaceutical CMO & CRO Revenue by Type (2017-2022) & (USD Million)
Table 96. South America Biopharmaceutical CMO & CRO Revenue by Type (2023-2028) & (USD Million)
Table 97. South America Biopharmaceutical CMO & CRO Revenue by Application (2017-2022) & (USD Million)
Table 98. South America Biopharmaceutical CMO & CRO Revenue by Application (2023-2028) & (USD Million)
Table 99. South America Biopharmaceutical CMO & CRO Revenue by Country (2017-2022) & (USD Million)
Table 100. South America Biopharmaceutical CMO & CRO Revenue by Country (2023-2028) & (USD Million)
Table 101. Middle East & Africa Biopharmaceutical CMO & CRO Revenue by Type (2017-2022) & (USD Million)
Table 102. Middle East & Africa Biopharmaceutical CMO & CRO Revenue by Type (2023-2028) & (USD Million)
Table 103. Middle East & Africa Biopharmaceutical CMO & CRO Revenue by Application (2017-2022) & (USD Million)
Table 104. Middle East & Africa Biopharmaceutical CMO & CRO Revenue by Application (2023-2028) & (USD Million)
Table 105. Middle East & Africa Biopharmaceutical CMO & CRO Revenue by Country (2017-2022) & (USD Million)
Table 106. Middle East & Africa Biopharmaceutical CMO & CRO Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Biopharmaceutical CMO & CRO Picture
Figure 2. Global Biopharmaceutical CMO & CRO Revenue Market Share by Type in 2021
Figure 3. Biologics
Figure 4. Biosimilars
Figure 5. Biopharmaceutical CMO & CRO Revenue Market Share by Application in 2021
Figure 6. Contract Manufacturing Picture
Figure 7. Contract Research Picture
Figure 8. Global Biopharmaceutical CMO & CRO Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 9. Global Biopharmaceutical CMO & CRO Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Biopharmaceutical CMO & CRO Revenue Market Share by Region (2017-2028)
Figure 11. Global Biopharmaceutical CMO & CRO Revenue Market Share by Region in 2021
Figure 12. North America Biopharmaceutical CMO & CRO Revenue (USD Million) and Growth Rate (2017-2028)
Figure 13. Europe Biopharmaceutical CMO & CRO Revenue (USD Million) and Growth Rate (2017-2028)
Figure 14. Asia-Pacific Biopharmaceutical CMO & CRO Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. South America Biopharmaceutical CMO & CRO Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Middle East and Africa Biopharmaceutical CMO & CRO Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Biopharmaceutical CMO & CRO Market Drivers
Figure 18. Biopharmaceutical CMO & CRO Market Restraints
Figure 19. Biopharmaceutical CMO & CRO Market Trends
Figure 20. Lonza Recent Developments and Future Plans
Figure 21. Boehringer Ingelheim GmbH Recent Developments and Future Plans
Figure 22. Rentschler Biotechnologie GmbH Recent Developments and Future Plans
Figure 23. Inno Biologics Sdn Bhd Recent Developments and Future Plans
Figure 24. JRS Pharma (Celonic GmbH) Recent Developments and Future Plans
Figure 25. BIOMEVA GmbH Recent Developments and Future Plans
Figure 26. ProBioGen Recent Developments and Future Plans
Figure 27. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Recent Developments and Future Plans
Figure 28. TOYOBO CO., LTD Recent Developments and Future Plans
Figure 29. Samsung BioLogics Recent Developments and Future Plans
Figure 30. Patheon Recent Developments and Future Plans
Figure 31. CMC Biologics Recent Developments and Future Plans
Figure 32. Binex Co., Ltd. Recent Developments and Future Plans
Figure 33. AbbVie Inc. Recent Developments and Future Plans
Figure 34. WuXi Biologics. Recent Developments and Future Plans
Figure 35. Global Biopharmaceutical CMO & CRO Revenue Share by Players in 2021
Figure 36. Biopharmaceutical CMO & CRO Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 37. Global Top 3 Players Biopharmaceutical CMO & CRO Revenue Market Share in 2021
Figure 38. Global Top 10 Players Biopharmaceutical CMO & CRO Revenue Market Share in 2021
Figure 39. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 40. Global Biopharmaceutical CMO & CRO Revenue Share by Type in 2021
Figure 41. Global Biopharmaceutical CMO & CRO Market Share Forecast by Type (2023-2028)
Figure 42. Global Biopharmaceutical CMO & CRO Revenue Share by Application in 2021
Figure 43. Global Biopharmaceutical CMO & CRO Market Share Forecast by Application (2023-2028)
Figure 44. North America Biopharmaceutical CMO & CRO Sales Market Share by Type (2017-2028)
Figure 45. North America Biopharmaceutical CMO & CRO Sales Market Share by Application (2017-2028)
Figure 46. North America Biopharmaceutical CMO & CRO Revenue Market Share by Country (2017-2028)
Figure 47. United States Biopharmaceutical CMO & CRO Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Canada Biopharmaceutical CMO & CRO Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Mexico Biopharmaceutical CMO & CRO Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Europe Biopharmaceutical CMO & CRO Sales Market Share by Type (2017-2028)
Figure 51. Europe Biopharmaceutical CMO & CRO Sales Market Share by Application (2017-2028)
Figure 52. Europe Biopharmaceutical CMO & CRO Revenue Market Share by Country (2017-2028)
Figure 53. Germany Biopharmaceutical CMO & CRO Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. France Biopharmaceutical CMO & CRO Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. United Kingdom Biopharmaceutical CMO & CRO Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Russia Biopharmaceutical CMO & CRO Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Italy Biopharmaceutical CMO & CRO Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Asia-Pacific Biopharmaceutical CMO & CRO Sales Market Share by Type (2017-2028)
Figure 59. Asia-Pacific Biopharmaceutical CMO & CRO Sales Market Share by Application (2017-2028)
Figure 60. Asia-Pacific Biopharmaceutical CMO & CRO Revenue Market Share by Region (2017-2028)
Figure 61. China Biopharmaceutical CMO & CRO Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Japan Biopharmaceutical CMO & CRO Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South Korea Biopharmaceutical CMO & CRO Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. India Biopharmaceutical CMO & CRO Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Southeast Asia Biopharmaceutical CMO & CRO Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Australia Biopharmaceutical CMO & CRO Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. South America Biopharmaceutical CMO & CRO Sales Market Share by Type (2017-2028)
Figure 68. South America Biopharmaceutical CMO & CRO Sales Market Share by Application (2017-2028)
Figure 69. South America Biopharmaceutical CMO & CRO Revenue Market Share by Country (2017-2028)
Figure 70. Brazil Biopharmaceutical CMO & CRO Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Argentina Biopharmaceutical CMO & CRO Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Middle East and Africa Biopharmaceutical CMO & CRO Sales Market Share by Type (2017-2028)
Figure 73. Middle East and Africa Biopharmaceutical CMO & CRO Sales Market Share by Application (2017-2028)
Figure 74. Middle East and Africa Biopharmaceutical CMO & CRO Revenue Market Share by Country (2017-2028)
Figure 75. Turkey Biopharmaceutical CMO & CRO Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Biopharmaceutical CMO & CRO Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. UAE Biopharmaceutical CMO & CRO Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Methodology
Figure 79. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
